Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
Katrina G. Ferguson, Maine Medical Center
ClinicalTrials.gov Identifier:
NCT01656616
First received: August 1, 2012
Last updated: May 16, 2017
Last verified: May 2017
  Purpose
The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.

Condition Intervention
Cyanide Poisoning
Drug: Cyanide antidote administration

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

Resource links provided by NLM:


Further study details as provided by Maine Medical Center:

Enrollment: 0
Actual Study Start Date: August 1, 2012
Study Completion Date: August 1, 2012
Primary Completion Date: August 1, 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
EMS cyanide exposure patients Drug: Cyanide antidote administration

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
EMS patients possibly exposed to cyanide via poisoning or smoke exposure.
Criteria

Inclusion Criteria:

  • Included in Maine EMS database
  • House Fire Victim
  • Poisoning

Exclusion Criteria:

  • No potential cyanide exposure
  • Incomplete data available
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01656616

Locations
United States, Maine
Maine Medical Center Department of Emergency Medicine
Portland, Maine, United States, 04102
Sponsors and Collaborators
Maine Medical Center
Investigators
Study Director: Tania D Strout, PhD, RN, MS Maine Medical Center
  More Information

Responsible Party: Katrina G. Ferguson, Director of Research, Department of Emergency Medicine, Maine Medical Center
ClinicalTrials.gov Identifier: NCT01656616     History of Changes
Other Study ID Numbers: IRB 4053X
Study First Received: August 1, 2012
Last Updated: May 16, 2017

Keywords provided by Maine Medical Center:
Pharmacoeconomics
Cost effectiveness
Cyanide
Fire
Emergency Medical Services
Smoke Inhalation

Additional relevant MeSH terms:
Emergencies
Poisoning
Disease Attributes
Pathologic Processes
Chemically-Induced Disorders
Hydroxocobalamin
Vitamin B 12
Antidotes
Hematinics
Vitamin B Complex
Vitamins
Micronutrients
Growth Substances
Physiological Effects of Drugs
Protective Agents

ClinicalTrials.gov processed this record on May 22, 2017